Our recent research has confirmed that the markedly elevated levels of follicle-stimulating hormone (FSH) during the perimenopausal period, along with the presence of the APOE ε4 allele, constitute significant risk factors contributing to the heightened susceptibility to AD in women [187,188]. This evidence concerns the gene APOE and Alzheimer disease.